• Paul S Myles, Joyce Yeung, W Scott Beattie, Elizabeth G Ryan, Stephane Heritier, and Colin J McArthur.
• Department of Anaesthesiology and Perioperative Medicine, Alfred Health, Melbourne, VIC, Australia; Department of Anaesthesiology and Perioperative Medicine, Monash University, Melbourne, VIC, Australia. Electronic address: p.myles@alfred.org.au.
• Br J Anaesth. 2023 Jun 1; 130 (6): 677686677-686.

AbstractLarge randomised trials provide the most reliable evidence of effectiveness of new treatments in clinical practice. However, the time and resources required to complete such trials can be daunting. An overarching clinical trial platform focused on a single condition or type of surgery, aiming to compare several treatments, with an option to stop any or add in new treatment options, can provide greater efficiency. This has the potential to accelerate knowledge acquisition and identify effective, ineffective, or harmful treatments faster. The master protocol of the platform defines the study population(s) and standardised procedures. Ineffective or harmful treatments can be discarded or study drug dose modified during the life cycle of the trial. Other adaptive elements that can be modified include eligibility criteria, required sample size for any comparison(s), randomisation assignment ratio, and the addition of other promising treatment options. There are excellent opportunities for anaesthetists to establish platform trials in perioperative medicine. Platform trials are highly efficient, with the potential to provide quicker answers to important clinical questions that lead to improved patient care.Copyright © 2022 British Journal of Anaesthesia. All rights reserved.

10 keywords...

hide…